GPT-Rosalind is a frontier reasoning model built for life sciences — genomics, protein analysis, drug discovery workflows. It's OpenAI's clearest signal yet that specialized vertical AI is the next frontier, not just bigger general models. If this works even half as well as claimed, pharmaceutical R&D timelines could compress dramatically.